Agios Pharma (AGIO) Tops Q2 EPS by 36c

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.19), $0.36 better than the analyst estimate of ($1.55). Revenue for the quarter came in at $40.41 million versus the consensus estimate of $11.28 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• inTEST Corp (INTT) reported Q2 Revenue ; Offers Guidance
• ExxonMobil Q2 profit falls short of forecasts, shares slide
• AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance